Refine by
Brain Cancer Suppliers & Manufacturers
31 companies found
based inHaymarket, AUSTRALIA
We build digital brain maps. Imagine trying to navigate the world without a map. You might struggle to find the right way, take a few wrong turns, bump into something unexpected, or remain lost forever. You might get to your destination, but it ...
Infinitome is a next-generation neuro research platform that enables groundbreaking data and image analysis of the brain - without the need for code. Our cloud-driven, HIPAA compliant research platform turns raw MRI data into detailed functional ...
based inBerlin, GERMANY
ALBEGA Medical is a newly established pharmaceutical company developing novel radiopharmaceuticals in oncology. Our lead compound is Tetrofosmin (TTF) that we are developing in 3 indications: GLIOTECT - a novel diagnostic for brain tumors, GLIOTHER ...
based inCambridge, MASSACHUSETTS (USA)
Sumitomo Pharma Oncology, Inc. is a developer of novel cancer therapeutics based in the U.S. and a wholly owned subsidiary of Sumitomo Pharma Co., Ltd. This U.S. entity, together with the oncology research and development teams in Japan, Cancer ...
based inTucson, ARIZONA (USA)
Novel therapeutics are lacking for Brain Cancer. Only four of the 217 FDA-approved oncology medicines are indicated for life-threatening brain cancers. The most recent approval was in 2009 and did not extend life expectancy. Patients deserve better ...
Only 4 of the 217 FDA-approved oncology medicines are indicated for life-threatening brain cancers. The most recent approval was in 2009, but this medicine did not extend life expectancy. Patients deserve better ...
based inHelsinki, FINLAND
Nexstim was established in 2000 to commercialise the opportunity of adding navigation to an existing transcranial magnetic stimulation (TMS) technology. The founders believed that navigation and making the TMS visible with the help of navigation is ...
Nexstim offers targeted and effective therapies and diagnostics for challenging brain diseases and disorders. Our technology is solidly grounded in scientific and clinical research. We closely collaborate with key opinion leaders who like us, ...
based inFoothill Ranch, CALIFORNIA (USA)
TAE Life Sciences (TLS) is a biologically-targeted radiation therapy company focused on developing novel treatments to improve the lives of patients with invasive, recurrent and difficult to treat cancers. Founded in 2017, TLS is the only company ...
TAE Life Sciences is committed to developing a portfolio of novel targeted boron drugs to expand the application of BNCT to other cancer types and to provide even better outcomes for indications historically treated with Boronophenylalanine (BPA), a ...
based inPalo Alto, CALIFORNIA (USA)
Nirmidas Biotech was founded in September of 2013. We are a member of the Janssen Labs (JLABS) and QB3 programs, the Stanford StartX Med Program, and the MIT Industrial Liaison Program (MIT ILP). We are also a StartX Med COVID-19 Task Force Company ...
based inMonmouth Junction, NEW JERSEY (USA)
MedChemExpress (MCE) offers a wide range of high-quality research chemicals and biochemicals (novel life-science reagents, reference compounds and natural compounds) for scientific use. We have professionally experienced and friendly staff to meet ...
SH-4-54 is a STAT inhibitor that binds to STAT3 and STAT5 with KDs of 300, 464 nM, ...
based inOlathe, KANSAS (USA)
TVAX Biomedical is a clinical stage development company advancing its novel targeted cell-based immunotherapy for the treatment of cancer. TVAX Biomedical is developing a paradigm-shifting cancer treatment that offers the promise of improved ...
TVAX®’s lead candidate (TVI-Brain-1) is being evaluated for the treatment of brain cancer and targets glioblastomas. The drug candidate has received Fast Track Designation by the US Food ...
based inToronto, ONTARIO (CANADA)
Theralase was one of the first companies in North America to bring CLT to patients and the first company in the world to bring personalized ACT to patients individual tissue characteristics. With our multi-discipline experience in physics, ...
Theralase is laser focused on advancing the cutting-edge Anti-Cancer Therapy (“ACT”) towards commercialization, providing an alternative treatment methodology for Non-Muscle Invasive Bladder Cancer (“NMIBC”) patients ...
based inTempe, ARIZONA (USA)
GT Medical Technologies, Inc. (GT), an Arizona-based medical device company, is focused on improving the lives of patients with brain tumors. GT has developed an innovative approach to treatment by combining a conformable collagen matrix with ...
based inMinnetonka, MINNESOTA (USA)
Monteris Medical was founded in 1999 with the sole focus to help patients suffering from neurological diseases. The company’s goal remains: to create a minimally invasive surgical option for use in the brain. Monteris is a private equity backed ...
Dependable skull fixation for neurosurgical devices. The only cranial fixation bolt with a robotic interface to enable precise laser delivery. ...
based inBudapest, HUNGARY
Mediso Medical Imaging Systems with headquarters in Budapest is a dynamic supplier of Nuclear Medicine and modern Hybrid Imaging techniques to the health care and medical research institutions of the world. The company was founded in 1990 by experts ...
High throughput triple detector SPECT camera for wide range of clinical applications. Starting camera for your advanced research & clinical environment. AnyScan® TRIO SPECT offers new dimensions in SPECT imaging with the applied extra ...
based inRichmond, BRITISH COLUMBIA (CANADA)
BioMark is an oncology-focused company with advanced near-to- market liquid biopsy diagnostic technologies. Our technology improves patient comfort, outcomes and early cancer detection. Biomark owns various intellectual properties, developed for the ...
based in, CHINA
Mol Scientific provides customized peptide synthesis services including linear peptides, modified peptides, protein cross-linked peptides and more. Mol Scientific is a national high-tech enterprise, committed to providing high quality products and ...
![Mol Scientific - Model MPE0009823 - Deleted in malignant brain tumors 1 protein [2385-2413] peptide](https://d32zuqhgcrpxli.cloudfront.net/eyJidWNrZXQiOiJlZS1maWxlcyIsImtleSI6ImZpbGVzLzEyNzQ2MS9pbWFnZXMvMTI3NDYxXzBfMjAyMjA4MTYwNzQ1MDkxNjk5ODQ1XzQwMC5wbmciLCJlZGl0cyI6eyJyZXNpemUiOnsiZml0IjoiY29udGFpbiIsImJhY2tncm91bmQiOnsiciI6MjU1LCJnIjoyNTUsImIiOjI1NSwiYWxwaGEiOjF9LCJ3aWR0aCI6MTQzLCJoZWlnaHQiOjEwMn19fQ== "Mol Scientific - Model MPE0009823 - Deleted in malignant brain tumors 1 protein [2385-2413] peptide")
Mol Scientific offer high-quality Deleted in malignant brain tumors 1 protein [2385-2413] peptide product(MPE0009823). Mol Scientific committed to bring our esteemed customers high quality products and the finest services at highly competitive ...
based inBuford, GEORGIA (US) (USA)
Continuing To Do More To Save More Lives. Theragenics was founded in 1981 and quickly became a global leader in the manufacture of radioactive brachytherapy seeds for the treatment of localized prostate cancer. We began diversifying operations in ...
based inNew York City, NEW YORK (USA)
Lauren Sciences is a privately-held New York biotechnology company focused on developing its V-Smart platform to create a robust pipeline of V-Smart therapeutics consisting of central nervous system (CNS)-active drugs that normally do not cross the ...
based inBurton upon Trent, UNITED KINGDOM
The Asbestos Testing and Consultancy Association (ATaC) is the leading trade association in the UK for the asbestos testing and consulting services sector. ATaC has represented the interests of asbestos testing and consultancy specialists for over ...
based inTampa, FLORIDA (USA)
infuseon therapeutics, inc. was founded in 2012 by Cleveland Clinic for the purpose of developing its patented unique therapeutic delivery device, the Cleveland Multiport Catheter™. This multiport convection-enhanced delivery catheter was designed ...
based inEttlingen, GERMANY
We are a pioneering medical device company focused on transforming the lives of patients with difficult to treat cancers by applying our discoveries in bioelectromagnetics to targeted treatment of cancer. Our patient-based research using low and ...